BeOne Medicines (ONC) Current Assets (2015 - 2026)

BeOne Medicines (ONC) has reported Current Assets for 12 consecutive years, with $6.6 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Current Assets rose 69.42% year-over-year to $6.6 billion; the TTM figure through Mar 2026 stood at $6.6 billion (up 69.42% YoY), while the FY2025 annual figure was $6.2 billion, up 56.17% from the prior year.
• Current Assets grew to $6.6 billion in Q1 2026 per ONC's latest filing, from $6.2 billion in the prior quarter.
• Across five years, Current Assets topped out at $6.9 billion in Q1 2022 and bottomed at $3.1 billion in Q4 2022.
• Historically, Current Assets has averaged $4.8 billion across 5 years, with a median of $4.3 billion in 2025.
• Annual changes were most pronounced in 2022 — Current Assets tumbled 59.33% — and 2026, when it jumped 69.42%.
• BeOne Medicines' Current Assets stood at $3.1 billion in 2022, then jumped by 35.74% to $4.2 billion in 2023, then dropped by 5.04% to $4.0 billion in 2024, then surged by 56.17% to $6.2 billion in 2025, then grew by 5.9% to $6.6 billion in 2026.
• Business Quant data shows ONC's Current Assets at $6.6 billion in Q1 2026, $6.2 billion in Q4 2025, and $5.7 billion in Q3 2025.